Financial

Biosceptre Secures £8.1 Million to Accelerate Innovative Cancer Therapies

Biosceptre Secures £8.1 Million to Accelerate Innovative Cancer Therapies

Biosceptre2025-10-03T10:04:06+10:00October 2nd, 2025|Corporate, Financial|

Cambridge, UK – 1 October 2025 – Biosceptre International Limited [...]

Closing Date Extension for £10 Million Placement to Eligible Existing Shareholders

Closing Date Extension for £10 Million Placement to Eligible Existing Shareholders

Biosceptre2025-08-06T11:02:24+10:00August 6th, 2025|Corporate, Financial|

6 August 2025 – Biosceptre International Limited ("Biosceptre" or "the [...]

Biosceptre Announces £10 Million Placement to Eligible Existing Shareholders

Biosceptre Announces £10 Million Placement to Eligible Existing Shareholders

Biosceptre2025-06-24T16:59:43+10:00June 24th, 2025|Corporate, Financial|

24 June 2025 – Biosceptre International Limited ("Biosceptre" or "the [...]

Biosceptre closes AUD5m financing from existing investors

Biosceptre2014-07-09T00:00:48+10:00July 9th, 2014|Clinical, Financial|

Funds to progress Phase I development of oncology product BIL-03s [...]